EIB Supports Dutch Biotech Company in Fight Against ALS

Reformatorisch Dagblad

welingelichtekringen.nl

View article

Reposted by

welingelichtekringen.nl

Right

Factuality

Ownership

The European Investment Bank (EIB) is providing a loan of 30 million euros to the Amsterdam-based biotech company VectorY Therapeutics. The company is developing new treatments for neurodegenerative diseases such as ALS, Huntington's disease, and Alzheimer's.

alborsaanews.com

Factuality

Ownership

The European Investment Bank announced a Euro30 million convertible loan to the Dutch biotechnology company Viktor Wei Theraputex, with the aim of accelerating the development of innovative treatments for neurodegenerative diseases, including adrenal sclerosis and Huntington's disease. In a press release, the Bank explained that funding for the company, based in the capital, Amsterdam, was supported by the Euro30 million program, a loan from Eur…

Nieuws.nl

Factuality

Ownership

AMSTERDAM (ANP) - The European Investment Bank (EIB) is providing a loan of 30 million euros to the Amsterdam-based biotech company VectorY Therapeutics. That company is working on the development of new treatments for neurodegenerative disorders such as ALS, Huntington's disease...